Clinical Trial Details
| Trial ID: | L3862 |
| Source ID: | NCT00174681 |
| Associated Drug: | Insulin Glargine |
| Title: | Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: Insulin Glargine |
| Outcome Measures: | Primary: Percentage of subjects achieving HbA1c < 7% at the end of the study. | |
| Sponsor/Collaborators: | Sponsor: Sanofi |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 390 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2003-04 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2011-01-11 |
| Locations: | Sanofi-Aventis, Zagreb, Croatia|Sanofi-Aventis, Prague, Czech Republic|Sanofi-Aventis, Paris, France|Sanofi-Aventis, Bucharest, Romania|Sanofi-Aventis, Moscow, Russian Federation|Sanofi-Aventis, Ljubljana, Slovenia |
| URL: | https://clinicaltrials.gov/show/NCT00174681 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|